Selected variants of the steroid-5-alpha-reductase isoforms SRD5A1 and SRD5A2 and the sex steroid hormone receptors ESR1, ESR2 and PGR: No association with female pattern hair loss identified

Experimental Dermatology

Volumn 21, Issue 5, 2012, Pages 390-393

  Redler, Silke ^a   Tazi Ahnini, Rachid ^b   Drichel, Dmitriy ^c   Birch, Mary P ^d   Brockschmidt, Felix F ^a   Dobson, Kathy ^d   Giehl, Kathrin A ^e   Refke, Melanie ^a   Kluck, Nadine ^a   Kruse, Roland ^f   Lutz, Gerhard ^g   Wolff, Hans ^e   Böhm, Markus ^h   Becker, Tim ^a,c   Nöthen, Markus M ^a   Betz, Regina C ^a   Messenger, Andrew ^d  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^d ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^f Dermatological Practice   (Germany)

^g Hair and Nail ^*  (Germany)

^h UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Association study; Female pattern hair loss; Sex steroid hormone receptors

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; PROGESTERONE RECEPTOR; STEROID 5ALPHA REDUCTASE 1; STEROID 5ALPHA REDUCTASE 2;

CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FEMALE PATTERN HAIR LOSS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HAIR LOSS; HUMAN; LETTER; MAJOR CLINICAL STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE; ALLELES; ALOPECIA; CASE-CONTROL STUDIES; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENETIC VARIATION; GERMANY; GREAT BRITAIN; HUMANS; MEMBRANE PROTEINS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 84859903821     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2012.01469.x     Document Type: Letter

References (40)

1. Birch M P, Messenger J F, Messenger A G. Br J Dermatol 2001: 144: 297-304.
2. Gan D C, Sinclair R D. J Investig Dermatol Symp Proc 2005: 10: 184-189.
3. Norwood O T. Dermatol Surg 2001: 27: 53-54.
4. Ludwig E. Br J Dermatol 1977: 97: 247-254.
5. Sinclair R, Jolley D, Mallari R et al. J Am Acad Dermatol 2004: 51: 189-199.
6. Kuster W, Happle R. Hautarzt 1983: 34: 539-547.
7. Nyholt D R, Gillespie N A, Heath A C et al. J Invest Dermatol 2003: 121: 1561-1564.
8. Smith M A, Wells R S. Arch Dermatol 1964: 89: 95-98.
9. Cela E, Robertson C, Rush K et al. Eur J Endocrinol 2003: 149: 439-442.
10. Riedel-Baima B, Riedel A. Endocr Regul 2008: 42: 13-16.
11. Vexiau P, Chaspoux C, Boudou P et al. Arch Dermatol Res 2000: 292: 598-604.
12. Carey A H, Chan K L, Short F et al. Clin Endocrinol (Oxf) 1993: 38: 653-658.
13. Kim Y, Marjoniemi V M, Diamond T et al. Australas J Dermatol 2003: 44: 62-66.
14. Cousen P, Messenger A. Br J Dermatol 2010: 162: 1135-1137.
15. Olsen E A. J Am Acad Dermatol 2001: 45: S70-S80.
16. Schmidt J B, Lindmaier A, Spona J. Dermatologica 1991: 182: 214-217.
17. Orme S, Cullen D R, Messenger A G. Br J Dermatol 1999: 141: 521-523.
18. Brockschmidt F F, Hillmer A M, Eigelshoven S et al. Br J Dermatol 2010: 162: 899-903.
19. Hillmer A M, Hanneken S, Ritzmann S et al. Am J Hum Genet 2005: 77: 140-148.
20. Cobb J E, Zaloumis S G, Scurrah K J et al. Exp Dermatol 2010: 19: 1026-1028.
21. el-Samahy M H, Shaheen M A, Saddik D E et al. Int J Dermatol 2009: 48: 584-587.
22. Redler S, Brockschmidt F F, Tazi-Ahnini R et al. Br J Dermatol 2012. Doi: 10.1111/j.1365-2133.2012.10877.x [epub ahead of print].
23. Sawaya M E, Price V H. J Invest Dermatol 1997: 109: 296-300.
24. Yip L, Zaloumis S, Irwin D et al. Br J Dermatol 2009: 161: 289-294.
25. Redler S, Birch M P, Drichel D et al. Br J Dermatol 2011: 165: 703-705.
26. Pelletier G, Ren L. Histol Histopathol 2004: 19: 629-636.
27. Thornton M J, Taylor A H, Mulligan K et al. J Investig Dermatol Symp Proc 2003: 8: 100-103.
28. Oh H S, Smart R C. Proc Natl Acad Sci USA 1996: 93: 12525-12530.
29. Ohnemus U, Uenalan M, Conrad F et al. Endocrinology 2005: 146: 1214-1225.
30. Crandall C J, Sehl M E, Crawford S L et al. Breast Cancer Res 2009: 11: R51.
31. Dahlman I, Vaxillaire M, Nilsson M et al. Pharmacogenet Genomics 2008: 18: 967-975.
32. Dunning A M, Healey C S, Baynes C et al. Hum Mol Genet 2009: 18: 1131-1139.
33. Lurie G, Wilkens L R, Thompson P J et al. Cancer Causes Control 2009: 20: 47-55.
34. Pooley K A, Healey C S, Smith P L et al. Cancer Epidemiol Biomarkers Prev 2006: 15: 675-682.
35. Rivadeneira F, Styrkarsdottir U, Estrada K et al. Nat Genet 2009: 41: 1199-1206.
36. Styrkarsdottir U, Halldorsson B V, Gretarsdottir S et al. N Engl J Med 2008: 358: 2355-2365.
37. Turnbull C, Ahmed S, Morrison J et al. Nat Genet 2010: 42: 504-507.
38. Wang J T, Guo Y, Yang T L et al. Bone 2008: 43: 910-914.
39. Yu K D, Rao N Y, Chen A X et al. Breast Cancer Res Treat 2011: 126: 37-45.
40. Li N, Dong J, Hu Z et al. Breast Cancer Res Treat 2010: 121: 177-184.